Systematic development of lectin conjugated microspheres for nose-to-brain delivery of rivastigmine for the treatment of Alzheimer’s disease
Yang Gao,Waleed H Almalki,Obaid Afzal,Sunil K Panda,Imran Kazmi,Majed Alrobaian,Hanadi A Katouah,Abdulmalik Saleh Alfawaz Altamimi,Fahad A Al-Abbasi,Sultan Alshehri,Kriti Soni,Ibrahim Abdel Aziz Ibrahim,Mahfoozur Rahman,Sarwar Beg,Waleed H. Almalki,Sunil K. Panda,Hanadi A. Katouah,Fahad A. Al-Abbasi
DOI: https://doi.org/10.1016/j.biopha.2021.111829
2021-09-01
Abstract:<p>The current study focuses on development of nasal mucoadhesive microspheres for nose-to-brain delivery of rivastigmine for Alzheimer treatment. A systematic development was employed for optimization of the formulation and process parameters influential on the quality attributes of the microspheres. The risk assessment study revealed major influence of the polymer concentration (ethylcellulose: chitosan), the concentration of surfactant solution (polyvinyl alcohol), and stirring speed as the critical factors for optimization of the microspheres. These factors were systematically optimized using Box-Behnken design and microspheres were evaluated for the particle size, entrapment efficiency, and <em>in vitro</em> drug release as the response variables. The optimized microspheres containing 4.4% wt/vol polymers, 1% wt/vol surfactant, and stirring speed at 1500 rpm showed particle size of 19.9 µm, entrapment efficiency of 77.8%, and drug release parameters as T<sub>80%</sub> of 7.3 h. The surface modification of microspheres was performed with lectin by carbodiimide activation reaction and confirmed by difference in surface charge before and after chemical functionalization by zeta potential measurement which was found to be − 25.7 mV and 20.5 mV, respectively. <em>Ex vivo</em> study for bioadhesion strength evaluation on goat nasal mucosa indicated a significant difference (p < 0.001) between the plain (29%) and lectin functionalized microspheres (64%). <em>In vivo</em> behavioral and biochemical studies in the rats treated with lectin functionalized microspheres showed markedly better memory-retention vis-à-vis test and pure drug solution treated rats (p < 0.001). In a nutshell, the present studies showed successful development of nasal microspheres for enhanced brain delivery of rivastigmine for Alzheimer's treatment.</p>
pharmacology & pharmacy,medicine, research & experimental